3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid
1
Leukemia
1
Interventions
Cyclophosphamide
21
fludarabine
17
Specimen Handling
13
Magnetic Resonance Spectroscopy
10
pembrolizumab
9
Nivolumab
9
Radiotherapy
7
Cisplatin
7
fludarabine phosphate
5
Injections
5
tislelizumab
4
daratumumab
4
Rituximab
4
Paclitaxel
4
Ipilimumab
4
Interleukin-2
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Fluorouracil
4
Drug Therapy
4
Doxorubicin
4
Dexamethasone
4
Carboplatin
4
Biopsy
4
venetoclax
3
toripalimab
3
X-Rays
3
Radiosurgery
3
Platinum
3
Oxaliplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
IPI-549
×
Clear all
NCT07439211
2026-03-03
GAVEL
Dana-Farber Cancer Institute
Phase 1
Not yet recruiting
48 enrolled